Literature DB >> 1383568

Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus.

W V Corapi1, C W Olsen, F W Scott.   

Abstract

Fifty-four monoclonal antibodies (MAbs) to feline infectious peritonitis virus (FIPV) were characterized according to protein specificity, immunoglobulin subclass, virus neutralization, reactivity with different coronaviruses, and ability to induce antibody-dependent enhancement (ADE) of FIPV infection in vitro. The MAbs were found to be specific for one of three structural proteins of FIPV. A total of 47 MAbs were specific for the 205-kDa spike protein (S), 3 MAbs were specific for the 45-kDa nucleocapsid protein (N), and 4 MAbs were specific for the 26- to 28-kDa membrane protein (M). The S-specific MAbs showed various degrees of cross-reactivity with strains of FIPV, feline enteric coronavirus, canine coronavirus, and porcine transmissible gastroenteritis virus. Nineteen S-specific MAbs neutralized FIPV. A total of 15 of the neutralizing MAbs induced ADE, and all but 1 were of the immunoglobulin G2a subclass. The remaining four neutralizing MAbs that did not induce ADE were of the immunoglobulin G1 subclass. Two S-specific MAbs induced ADE but were nonneutralizing. None of the N- or M-specific MAbs was neutralizing or induced ADE. On the basis of the reactivity patterns of the MAbs with FIPV and related coronaviruses, it was concluded that there is a minimum of five neutralizing sites on S. In most instances, neutralizing MAbs were able to induce ADE, demonstrating a direct relationship between neutralization and enhancement. The difference in immunoglobulin subclass between neutralizing MAbs that induced ADE and those that did not induce ADE suggests that there may be a restriction in the immunoglobulin subclasses capable of mediating ADE.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383568      PMCID: PMC240165     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.

Authors:  B J Mady; D V Erbe; I Kurane; M W Fanger; F A Ennis
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

2.  Morphologic and physical characteristics of feline infectious peritonitis virus and its growth in autochthonous peritoneal cell cultures.

Authors:  N C Pedersen
Journal:  Am J Vet Res       Date:  1976-05       Impact factor: 1.156

3.  Serologic studies of naturally occurring feline infectious peritonitis.

Authors:  N C Pedersen
Journal:  Am J Vet Res       Date:  1976-12       Impact factor: 1.156

4.  Feline infectious peritonitis: a worldwide serosurvey.

Authors:  M C Horzinek; A D Osterhaus
Journal:  Am J Vet Res       Date:  1979-10       Impact factor: 1.156

5.  Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

6.  Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages.

Authors:  C W Olsen; W V Corapi; C K Ngichabe; J D Baines; F W Scott
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses.

Authors:  T Hohdatsu; S Okada; H Koyama
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.

Authors:  T Hohdatsu; M Nakamura; Y Ishizuka; H Yamada; H Koyama
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens.

Authors:  H Vennema; R J de Groot; D A Harbour; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

View more
  64 in total

1.  Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease.

Authors:  Jolanda D F de Groot-Mijnes; Jessica M van Dun; Robbert G van der Most; Raoul J de Groot
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Infectivity-neutralizing and hemagglutinin-inhibiting antibody responses to respiratory coronavirus infections of cattle in pathogenesis of shipping fever pneumonia.

Authors:  X Lin; K L O'Reilly; M L Burrell; J Storz
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 3.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

4.  Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.

Authors:  M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

5.  Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement.

Authors:  W V Corapi; R J Darteil; J C Audonnet; G E Chappuis
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR.

Authors:  A A Herrewegh; R J de Groot; A Cepica; H F Egberink; M C Horzinek; P J Rottier
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Immunogenicity of a viral model vaccine after different inactivation procedures.

Authors:  M F Bachmann; C Bast; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

8.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

9.  Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine.

Authors:  Tais A P F Pimentel; Zhe Yan; Scott A Jeffers; Kathryn V Holmes; Robert S Hodges; Peter Burkhard
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.